<DOC>
	<DOCNO>NCT02622880</DOCNO>
	<brief_summary>The purpose study evaluate effect immune formula , consume 10 day surgery , number characteristic postoperative infection period 30 day group oropharynx , hypopharynx , larynx oral cavity squamous cell cancer patient , candidate surgery .</brief_summary>
	<brief_title>Comparison Two Immunomodulatory Formulas Number Postoperative Infections Head &amp; Neck Cancer Patients</brief_title>
	<detailed_description>68 subject randomize two study group : 34 subject consume supplement study 34 control consume supplement IMPACT . Intervention period 10 day surgery . The consume amount 400 ml/ day . The Subjects stratify accord tumor location ( larynx oral cavity oropharynx , hypopharynx ) disease stage ( early advance ) .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Men woman &gt; 18 year Patients histologically confirm squamous cell cancer oropharynx , hypopharynx , larynx oral cavity candidate neoplastic surgery ( undergoing surgery ) Adequate cultural level understand clinical trial . agree participate voluntarily study give write informed consent Patients participate clinical trial Patients active infectious process time study . Patients undergone radiotherapy / chemotherapy prior surgery . Subjects diagnose Type I Diabetes Mellitus Subjects use oral hypoglycemic agent insulin . Patients severe kidney disease , heart , respiratory liver . Patients autoimmune disease immunosuppressive drug use . Subjects dementia , mental illness diminish cognitive function . Subjects refuse oral supplement . Subjects consume vitamin supplement artificial nutrition , suspend least 1 week study accept suspend study . Subjects morbid obesity ( BMI â‰¥ 40 kg / m2 ) . Pregnant breastfeeding Patients diagnose epidermoid carcinoma T1 glottic , cordectomy candidate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>